Aesica concentrates investment in German formulations business
Zwickau site introduces roller compaction unit for dry granulation production
Aesica Pharmaceuticals is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany after identifying this area as a key growth market within the domestic market.
The company is committed to capitalising on the presence of its German sites (Monheim and Zwickau), having identified the German pharma economy as a growth area for its services and is planning to take an increasing share of the market. This latest investment compliments other recent investments in the region, including a new tablet coater capability and pouch packing line, enhancing a diverse range of capabilities it has within the country.
The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.
Other news from the department business & finance
